Skip to main content

DaVita U. S. Dialysis And Related Lab Services revenue

  • DVA · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$174.56+0.28%Close 13 Nov 2026 · Market value $11.03B

U. S. Dialysis And Related Lab Services revenue at DaVita came to $3.0B for the quarter to 30 Sep 2026, up 2.0% from a year earlier.

As DaVita reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$2.8BDec 2023$2.7BMar 2024$2.8BJun 2024$2.9BSep 2024$2.9BDec 2024$2.8BMar 2025$2.9BJun 2025$3.0BSep 2025$3.1BDec 2025$2.9BMar 2026$3.0BJun 2026$3.0BSep 2026
DaVita U. S. Dialysis And Related Lab Services revenue, every reported period
Period endingU. S. Dialysis And Related Lab Services revenueChange on a yearFiled
30 Sep 2026$3.0Bup 2.0%29 Oct 2026
30 Jun 2026$3.0Bup 3.6%4 Aug 2026
31 Mar 2026$2.9Bup 3.9%5 May 2026
31 Dec 2025$3.1Bup 6.5%11 Feb 2026
30 Sep 2025$3.0Bup 2.7%29 Oct 2025
30 Jun 2025$2.9Bup 2.4%5 Aug 2025
31 Mar 2025$2.8Bup 2.9%12 May 2025
31 Dec 2024$2.9Bup 2.9%13 Feb 2025
30 Sep 2024$2.9Bup 4.8%29 Oct 2024
30 Jun 2024$2.8Bup 4.4%6 Aug 2024
31 Mar 2024$2.7Bup 5.5%2 May 2024
31 Dec 2023$2.8Bup 5.8%14 Feb 2024
30 Sep 2023$2.8Bup 2.9%7 Nov 2023
30 Jun 2023$2.7Bup 2.5%3 Aug 2023
31 Mar 2023$2.6Bup 1.4%8 May 2023
31 Dec 2022$2.6Bdown 1.7%22 Feb 2023
30 Sep 2022$2.7Bup 0.2%31 Oct 2022
30 Jun 2022$2.6Bdown 0.4%1 Aug 2022
31 Mar 2022$2.6Bdown 0.2%5 May 2022
31 Dec 2021$2.7Bup 1.8%11 Feb 2022
30 Sep 2021$2.7Bup 0.9%28 Oct 2021
30 Jun 2021$2.7Bup 0.7%3 Aug 2021
31 Mar 2021$2.6Bdown 0.8%29 Apr 2021
31 Dec 2020$2.6B—12 Feb 2021
30 Sep 2020$2.7B—28 Oct 2021
30 Jun 2020$2.6B—3 Aug 2021
31 Mar 2020$2.6B—29 Apr 2021

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of DaVita: · financial statements

Every KPI and segment of DVA, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.